Header Logo

Connection

LOIS M RAMONDETTA to Ondansetron

Back to Details
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Ondansetron.
LOIS M RAMONDETTA
Connection Strength
0.177
Ondansetron
  1. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. 2021 Jan; 29(1):213-222.
    View in: PubMed
    Score: 0.177
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.